ArticleProceedings (Baylor University. Medical Center)2026
Increasing incidence of hepatobiliary cancer in adolescents and young adult females: a Surveillance, Epidemiology, and End Results database study.
Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Why is early-onset cancer on the rise?Proceedings (Baylor University. Medical Center) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent studies suggest shifting epidemiological patterns in hepatobiliary cancers (HBC), with an increasing incidence among younger populations. This study evaluated incidence and mortality trends of HBC in adolescents and young adults (AYA) in the United States.
methodsWe conducted a retrospective population-based study using SEER 21 Registries. Individuals aged 15 to 39 years diagnosed with liver and intrahepatic bile duct cancers from 2000 to 2022 were included. Adults aged 40 to 64 years served as a comparator group. Age-adjusted incidence (AAI) and mortality rates (MR) per 100,000 were calculated, and trends were analyzed using annual percent change (APC).
resultsAmong AYA, AAI increased from 0.34 (95% confidence interval [CI] 0.29-0.40) per 100,000 in 2000 to 0.56 (95% CI 0.49-0.63) in 2022. This was driven by an increase among females: APC 3.18%, 95% CI 2.24-4.30. Hispanic females had the greatest increase, with an APC of 6.96% (95% CI 4.07-20.03). The incidence in adults aged 40 to 64 years peaked in 2014 and declined thereafter. Mortality increased in AYA females (APC 0.99%, 95% CI 0.27-1.75), while remaining stable in males.
conclusionHBC incidence is rising among AYAs in the United States, disproportionately affecting females, especially Hispanic women, and is accompanied by increasing mortality. Further research is needed to identify underlying causes, including potential metabolic risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.